Evidence map›Paper›PMID 40871264›Full record

ArticleMicroorganisms2025

Prebiotic Xylo-Oligosaccharides Modulate the Gut Microbiome to Improve Innate Immunity and Gut Barrier Function and Enhance Performance in Piglets Experiencing Post-Weaning Diarrhoea.

James S Stanley, Stephen C Mansbridge, Michael R Bedford, Ian F Connerton, Kenneth H Mellits

Abstract read
In one paragraph

Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Soluble Dietary Fiber fromInternational journal of molecular sciences · 2026
    Article
  2. Immunomodulatory Effects ofBiomolecules · 2026
    Article
  3. Characterization of Xyloglucanase TpXEG12a fromInternational journal of molecular sciences · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

James S StanleyDivision of Microbiology, Brewing, and Biotechnology, School of Biosciences, University of Nottingham, Sutton Bonington LE12 5RD, UK.ORCID 0000-0003-2972-5358
Stephen C MansbridgeThe National Institute of Poultry Husbandry, Harper Adams University, Newport TF10 8NB, UK.ORCID 0000-0003-4246-9782
Michael R BedfordAB Vista, Marlborough SN8 4AN, UK.ORCID 0000-0002-5308-4290
Ian F ConnertonDivision of Microbiology, Brewing, and Biotechnology, School of Biosciences, University of Nottingham, Sutton Bonington LE12 5RD, UK.ORCID 0000-0001-8652-8938
Kenneth H MellitsDivision of Microbiology, Brewing, and Biotechnology, School of Biosciences, University of Nottingham, Sutton Bonington LE12 5RD, UK.

Funding

Biotechnology and Biological Sciences Research Council BB/T008369/1
6 · The paper itself

Abstract

During commercial pig production, weaning is a major stressor that disrupts the gut microbiome, compromises intestinal barrier integrity, and increases the susceptibility of piglets to pathogens. This often results in post-weaning diarrhoea (PWD), leading to growth retardation, morbidity, and economic loss. This study investigated the effects of dietary xylo-oligosaccharide (XOS) supplementation on the growth performance and gut health of 216 piglets with naturally occurring PWD. Piglets received either 0 (CON), 50 (XOS-50), or 500 (XOS-500) mg XOS/kg feed from weaning at 28 days of age (d1) for 54 days. XOS-500 significantly improved body weight at d22 and d54, but had no effect on average daily gain, daily feed intake (DFI), or feed conversion ratio. The intestinal microbiota alpha-diversity was unaffected by XOS, though jejunal beta diversity differed between CON and XOS-500 groups at d22. Jejunal Chao richness correlated positively with d54 body weight, while ileal Chao richness correlated negatively with DFI.

Indexed as

dietary carbohydratesgrowthhistologyimmunityintestinal healthmicrobiotaoligosaccharidespigsprebiotics

Identifiers

PMID40871264
PMCPMC12388265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.